An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.
Source summary generated July 17, 2026; this date does not indicate completed review.
Quotes from three independent practitioners, with their sources. Research context only.
What it is and how it works
From the published literature on Urolithin A; the papers are listed at the end. Research summary, not a recommendation.
What it is
Urolithin A is not a peptide: it is a small molecule that gut bacteria make from ellagitannins and ellagic acid, plant compounds found in pomegranates, walnuts and some berries. How much a person makes depends on their gut bacteria, and many people make little or none. A synthetic purified form is sold as a supplement (best known under the brand Mitopure from the Swiss company Amazentis, now Timeline), which sponsored most of the human trials.
How it works
Urolithin A switches on mitophagy, the process by which a cell tags worn-out mitochondria (the cell's energy-producing compartments) and recycles them so healthier ones can replace them. Mitophagy declines with age, and damaged mitochondria accumulate in muscle and other tissues. In worms urolithin A prevented this build-up and extended life span, and in aged mice it improved exercise capacity. In human muscle biopsies it raised proteins linked to mitophagy and mitochondrial metabolism and lowered blood acylcarnitines, by-products that rise when mitochondria burn fat inefficiently. In mice and in a human trial it also shifted immune T cells toward a younger, less exhausted profile.
What it has been studied for
Muscle endurance and strength in older and middle-aged adults (randomized trials)
Mitochondrial health markers in blood and muscle (randomized trials)
Age-related immune decline (randomized trial)
Life span and muscle function in aging animals (animal studies)
Strength of the evidence
Human trialsSeveral randomized placebo-controlled trials in older and middle-aged adults have been published, most sponsored by the supplement's maker, with mixed results on their primary endpoints.
What the literature reports on safety
In rat toxicology studies urolithin A was not genotoxic and caused no organ toxicity even at the highest dose tested, and the human trials reported it as safe and well tolerated over up to four months. It is sold in the United States as a dietary supplement ingredient under a Generally Recognized as Safe (GRAS) notice, not as an approved drug. Most clinical data come from studies funded by the company that sells it.
Review · D'Amico D, Andreux PA, et al. · Trends in Molecular Medicine (2021) · PMID 34030963
Reviewed how urolithin A is made in the gut, its mitophagy-based mechanism, and the animal and early human evidence across muscle, brain, gut and joint conditions.
Randomized trial · Liu S, D'Amico D, et al. · JAMA Network Open (2022) · PMID 35050355
In 66 adults around age 72, urolithin A improved hand and leg muscle endurance and lowered blood markers of poor mitochondrial function and inflammation, but did not significantly improve the 6-minute walk or peak muscle energy production.
Randomized trial · Singh A, D'Amico D, et al. · Cell Reports Medicine (2022) · PMID 35584623
In a company-sponsored trial in middle-aged adults, muscle strength rose about 12% and mitophagy proteins increased in muscle, but the primary endpoint (peak power output) did not improve.
Randomized trial · Denk D, Singh A, et al. · Nature Aging (2025) · PMID 41174221
In 50 healthy middle-aged adults, four weeks of urolithin A increased naive-like, less exhausted CD8 T cells and their capacity to burn fat for energy compared with placebo.
The first human trial, in healthy sedentary elderly people, found urolithin A was safe, reached the blood, and shifted muscle mitochondrial gene expression and blood acylcarnitines over four weeks.
Animal study · Heilman J, Andreux P, et al. · Food and Chemical Toxicology (2017) · PMID 28757461
Standard genetic-damage tests were negative and rats fed urolithin A for up to 90 days showed no changes in blood chemistry, blood counts or organs, even at the highest level tested.
Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), written 2026-11-06.
Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.
What have the teachers said about Urolithin A? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.
AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.